HOME >> MEDICINE >> NEWS
Substantial survival increase after highly active antiretroviral therapy for HIV-1 infection

Research published in this week's issue of The Lancet highlights the substantial increased survival for people with HIV-1 since the introduction of highly active antiretroviral therapy (HAART) in 1997. However the study also shows a shift in risk profiles compared with earlier data-people over 45 years no longer appear to have reduced survival compared with younger people, and individuals who acquire HIV-1 infection from injecting drug use have mortality rates four times greater than infection acquired from homosexual contact.

Using data from a large collaboration of 22 studies in Europe, Australia, and Canada (CASCADE), Kholoud Porter from the UK Medical Research Council Clinical Trials Unit and colleagues assessed the continuing effect of HAART on survival and progression to AIDS after HIV-1 seroconversion (the point at which antibodies to HIV-1 infection are detectable in blood). The investigators compared the effects of age at seroconversion, exposure category, sex, and presentation during acute HIV-1 infection pre-1997 (pre-HAART), in 1997-98 (limited use of HAART), and 1999-2001 (widespread use of HAART).

Compared with pre-1997 data, death rates were reduced by 50% in 1997, and by over 80% by 2001; during this time use of HAART therapy increased from 22% in 1997 to 57% in 2001. The largest reduction in mortality occured soon after HAART first became available in 1997.

By contrast with the pre-HAART era, injecting drug users had death rates four times greater in 1999-2001 than men infected through homosexual contact. Whereas pre-1997 the risk of AIDS was higher in those aged 45 years or older at seroconversion than in people who were 16-24 years, there was little evidence of a difference in risk by age in 1999-2001.

Kholoud Porter comments: "Now that HAART therapy is available, 9 out of 10 people infected with HIV-1 can expect to survive more than 10 years, regardless of their age. Earlier diagnosis provides opportunities t
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
16-Oct-2003


Page: 1 2

Related medicine news :

1. Substantial increase in breast cancer risk from combination hormone replacement therapy
2. Substantial increase in death rate after bypass surgery for people with anaemia
3. Maxim Phase II Clinical Trial Highlights Substantial Increase In Leukemia-FreeSurvival For Acute Myelogenous Leukemia Patients
4. Hormonal treatment improves survival in high-risk prostate cancer patients
5. Lack of clinical trial participation may contribute to lower survival rates
6. Alcohol relapse adversely affects 10-year liver transplant survival
7. Donor age has no affect on long-term liver transplant survival
8. Specialist care gives better rate of survival
9. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
10. New treatment options for some difficult cancers improve survival and quality of life
11. Medical technologies may hinder rather than help newborn survival

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/11/2019)... ... January 11, 2019 , ... Women’s Excellence ... inflammatory endometriosis tissue, relieve pain, and help restore fertility. , Endometriosis is a ... cases, tissue typically grows on the ovaries, fallopian tubes, and the inner lining ...
(Date:1/10/2019)... ... ... Dr. Samuel Joseph, Jr. , assisted by Dr. Andrew Moulton of Joseph ... 3D Printed Aries Titanium Spinal Implant . “As a surgeon, it’s very exciting to ... commented Dr. Joseph, founder of Joseph Spine. “Today we were able to successfully implement this ...
(Date:1/10/2019)... ... 2019 , ... The Karis Group, an Austin, Texas based company, announced today ... Officer effective immediately. Mr. Jiwa succeeds the past Chief Executive Officer, Mike Martin, ... transition was announced as part of an orderly succession plan and transition of leadership ...
(Date:1/10/2019)... DIEGO (PRWEB) , ... January 10, 2019 , ... ... education on CBD and Hemp companies, partners with NeuCana Companion to educate dog ... owners. , CBD is believed to help calm pain and anxiety related ailments ...
(Date:1/8/2019)... ... 2019 , ... Cigna-HealthSpring’s Medicare Advantage (MA) customers in or ... a new option for their medical care with the addition of JenCare ... centers in Atlanta that provide access to primary care physicians and specialist doctors, ...
Breaking Medicine News(10 mins):
(Date:1/14/2019)... ... ... Datalogic , a global leader in the automatic data capture and process ... one of the few rugged devices validated by the “Android Enterprise Recommended” program from ... PDA devices from Datalogic. It offers a slim and compact design while delivering ...
(Date:1/11/2019)... (PRWEB) , ... January 11, 2019 , ... According to ... to Top Acupuncture , people are now able to receive the respiratory treatment ... diseases. We focus on the root causes of imbalance as well. Acupuncture and Chinese ...
(Date:1/11/2019)... ... January 11, 2019 , ... ... ranked among the top US security companies for consecutive years, proudly announces their ... This award recognizes companies that excel at employee relations, use innovation to motivate ...
Breaking Medicine Technology:
Cached News: